Disc Medicine, Inc. (IRON) vs Recursion Pharmaceuticals, Inc. (RXRX)
- Disc Medicine, Inc. IRON 56.80 +0.26%
- Recursion Pharmaceuticals, Inc. RXRX 3.47 −16.59%
Disc Medicine, Inc. and Recursion Pharmaceuticals, Inc. are both Biotechnology companies. Disc Medicine, Inc. and Recursion Pharmaceuticals, Inc. are of similar size ($2.2B and $2.2B). Disc Medicine, Inc. has the higher net margin (0.00% vs −945.9%) and the higher return on invested capital (0.00% vs −92.2%). Across the 14 metrics below, Disc Medicine, Inc. leads on 9 and Recursion Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | IRON | RXRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 3.48% | 65.16% |
| Operating margin | 0.00% | (991.72%) | 0.00% |
| Net margin | 0.00% | (945.92%) | 0.00% |
| Free cash flow margin | 0.00% | (645.82%) | 0.00% |
| Return on equity | (39.08%) | (56.58%) | (56.36%) |
| Return on assets | (35.12%) | (41.26%) | (48.04%) |
| Return on invested capital | 0.00% | (92.22%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack